Loading...
cbdMD Inc (YCBD) is not a strong buy at the moment for a beginner, long-term investor. The technical indicators suggest a bearish trend, financial performance shows declining profitability, and there are no strong positive catalysts or trading signals to support immediate action. Holding or exploring alternative investments may be a better approach.
The stock exhibits bearish technical indicators. MACD is below 0 and negatively contracting, RSI is neutral at 42.894, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). Key support is at 0.719, with resistance at 0.994. The stock has a 70% chance of declining in the next day and week, with a slight recovery potential over the next month.
Gross margin increased by 12.07% YoY in Q4 2025, showing some improvement in cost efficiency.
Net income dropped significantly by -41.14% YoY, and EPS declined by -94.33% YoY in Q4 2025, indicating worsening profitability. Technical indicators are bearish, and no significant trading trends are observed from hedge funds or insiders.
In Q4 2025, revenue increased by 3.61% YoY to $4,720,770, but net income dropped to -$679,968 (-41.14% YoY), and EPS fell to -0.08 (-94.33% YoY). Gross margin improved to 53.28% (+12.07% YoY), but overall financial performance remains weak.
No recent analyst rating or price target updates available.